Assess your readiness to meet current and future reporting requirements.

Even as government and regulatory scrutiny on Health Care Professional (HCP) aggregate spend expands, many life sciences companies are not ready to meet these new reporting requirements in an efficient and reliable manner, increasing the risk of non-compliance. Non-compliant companies not only face punitive actions including fines but also may feel the impact to their reputation with investors and other stakeholders.